Transneural Therapeutics
- Biotech or pharma, therapeutic R&D
Transneural is developing a pipeline of novel non-hallucinogenic neuroplastogens designed to deliver efficacy across a diverse range of neuropsychiatric indications. Transneural merges AI with traditional drug development to synthesize novel therapeutics with the potential to deliver better efficacy and safety to the millions of people sidelined by MDD, PTSD, and other neuropsychiatric disorders. Transneural's leadership team has decades of experience developing and delivering blockbuster treatments to patients for depression, bipolar disorder, schizophrenia, and Alzheimer’s disease.
Address
Seattle Metro AreaWashington
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}